naltrexone has been researched along with oxytocin in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (24.00) | 18.7374 |
| 1990's | 7 (28.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 3 (12.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Armstrong, WE; Crowley, WR; Grosvenor, CE; Parker, SL; Wang, W | 1 |
| Koehler, E; McLemore, GL; Rosella-Dampman, LM; Summy-Long, JY | 1 |
| Kendrick, KM; Keverne, EB | 2 |
| Evans, RG; Olley, JE | 1 |
| Emmert, SE; Hartman, RD; Rosella-Dampman, LM; Summy-Long, JY | 1 |
| Rosella-Dampman, LM; Summy-Long, JY | 1 |
| Emmert, SE; Hartman, RD; Miller, DS; Rosella-Dampman, LM; Summy-Long, JY | 1 |
| Bade, V; Haldar, J | 1 |
| Bull, PM; Clarke, G; Douglas, AJ; MacMillan, SJ; McGrory, BG; Neumann, I; Russell, JA; Way, SA; Wright, DM | 1 |
| Hubbard, JI | 1 |
| Bicknell, RJ; Dye, S; Leng, G | 1 |
| Brown, CH; Leng, G; Ludwig, M | 1 |
| Lundeberg, T; Yu, LC; Yu, SQ | 1 |
| Lundeberg, T; Wang, JW; Yu, LC | 1 |
| Canpolat, S; Kelestimur, H; Kumru, S; Kutlu, S; Ozcan, M; Sandal, S; Yilmaz, B | 1 |
| Gao, L; Yu, LC | 1 |
| Chugh, C; Jain, H; Mediratta, PK; Rathi, N; Reeta, Kh; Sharma, KK | 1 |
| Gu, XL; Yu, LC | 1 |
| Bishop, VR; Brown, CH; Leng, G; Scott, V | 1 |
| Alijanpour, S; Amini-Khoei, H; Amiri, S; Banafshe, HR; Dehpour, AR; Haj-Mirzaian, A; Mehr, SE; Mesdaghinia, A; Mohammadi-Asl, A; Poursaman, S; Rastegar, M; Sadeghi, E; Samiei, E | 1 |
| Hsu, EA; Miller, JL; Perez, FA; Roth, CL | 1 |
| Christian, DG; Head, MA; Klockars, A; Levine, AS; Olszewski, PK | 1 |
| Bach, P; Kiefer, F; Klose, C; Koopmann, A; Krisam, J; Lenz, B; Limprecht, R; Pourbaix, M; Ries, M; Stenger, M; Thomas, BC; Vollstaedt-Klein, S; Zimmermann, S | 1 |
2 review(s) available for naltrexone and oxytocin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Maternal behaviour in sheep and its neuroendocrine regulation.
Topics: Anesthesia, Epidural; Animals; Animals, Newborn; beta-Endorphin; Estrogens; Female; Limbic System; Maternal Behavior; Microdialysis; Naltrexone; Oxytocin; Progesterone; Sheep | 1994 |
1 trial(s) available for naltrexone and oxytocin
| Article | Year |
|---|---|
ON-ICE trial: Investigation of the combined effects of oxytocin and naltrexone on stress-induced and alcohol cue-induced craving in alcohol use disorder-Study protocol of a phase II randomised double-blind placebo-controlled parallel-group trial.
Topics: Alcoholism; Clinical Trials, Phase II as Topic; Craving; Cues; Humans; Naltrexone; Neoplasm Recurrence, Local; Oxytocin; Randomized Controlled Trials as Topic | 2022 |
22 other study(ies) available for naltrexone and oxytocin
| Article | Year |
|---|---|
Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Domperidone; Dopamine; Dopamine Antagonists; Electric Stimulation; Female; Lactation; Naltrexone; Oxytocin; Pituitary Gland; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Vasopressins | 1991 |
Kappa opiate receptors inhibit release of oxytocin from the magnocellular system during dehydration.
Topics: Animals; Benzomorphans; Dehydration; Dynorphins; Endorphins; Hypertonic Solutions; Injections, Intraventricular; Male; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Osmolar Concentration; Oxytocin; Peptide Fragments; Pituitary Gland, Posterior; Protein Precursors; Radioimmunoassay; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Vasopressins | 1990 |
Effects of intracerebroventricular infusions of naltrexone and phentolamine on central and peripheral oxytocin release and on maternal behaviour induced by vaginocervical stimulation in the ewe.
Topics: Animals; Endorphins; Female; Injections, Intraventricular; Maternal Behavior; Naltrexone; Nervous System; Oxytocin; Phentolamine; Sheep | 1989 |
Comparison of the oxytocin response to water-deprivation, hyperosmolarity and administration of morphine or naltrexone in lactating and virgin female rats.
Topics: Animals; Female; Lactation; Morphine; Naltrexone; Oxytocin; Pregnancy; Rats; Reference Values; Saline Solution, Hypertonic; Water Deprivation | 1988 |
Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
Topics: Animals; Dehydration; Endorphins; Hypertonic Solutions; Hypothalamus; Male; Naltrexone; Osmosis; Oxytocin; Pituitary Gland, Posterior; Rats; Rats, Inbred Strains; Sodium Chloride; Vasopressins | 1986 |
Dexamethasone differentially alters naltrexone effects on vasopressin and oxytocin release during tail electroshock.
Topics: Animals; Body Weight; Dexamethasone; Electroshock; Hematocrit; Male; Naltrexone; Oxytocin; Pituitary Gland; Rats; Rats, Inbred Strains; Tail; Time Factors; Vasopressins | 1985 |
A functional role for opioid peptides in the differential secretion of vasopressin and oxytocin.
Topics: Animals; Arginine Vasopressin; Dehydration; Endorphins; Female; Hemorrhage; Hypothalamo-Hypophyseal System; Lactation; Male; Naltrexone; Oxytocin; Pregnancy; Rats; Rats, Inbred Strains | 1984 |
Involvement of opioid peptides in the inhibition of oxytocin release by heat stress in lactating mice.
Topics: Animals; Endorphins; Female; Lactation; Mice; Naltrexone; Oxytocin; Pregnancy; Stress, Physiological | 1981 |
Effects of the kappa-opioid agonist U50,488 on parturition in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Female; Infusions, Intravenous; Injections, Intravenous; Labor, Obstetric; Male; Morphine; Naloxone; Naltrexone; Oxytocin; Pregnancy; Pyrrolidines; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Opioid, kappa; Uterine Contraction | 1993 |
Water transport in cultured cells from the rat inner medullary collecting duct.
Topics: Animals; Arginine Vasopressin; Biological Transport; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Kidney Medulla; Kidney Tubules, Collecting; Naltrexone; Narcotic Antagonists; Osmosis; Oxytocin; Pyrrolidines; Rats; Receptors, Opioid, kappa; Water | 1996 |
Kappa-opioid restraint of oxytocin secretion: plasticity through pregnancy.
Topics: Animals; Basal Metabolism; Cholecystokinin; Female; Naloxone; Naltrexone; Oxytocin; Pregnancy; Pregnancy, Animal; Rats; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu; Secretory Rate | 1997 |
kappa-opioid regulation of neuronal activity in the rat supraoptic nucleus in vivo.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Cells, Cultured; Dendrites; Down-Regulation; Dynorphins; Electrophysiology; Female; Injections, Intravenous; Membrane Potentials; Microdialysis; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Oxytocin; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Supraoptic Nucleus; Vasopressins | 1998 |
Involvement of oxytocin in spinal antinociception in rats with inflammation.
Topics: Analgesics; Animals; Carrageenan; Hot Temperature; Inflammation; Injections, Spinal; Male; Naloxone; Naltrexone; Narcotic Antagonists; Oxytocin; Pain; Pain Measurement; Physical Stimulation; Rats; Rats, Wistar; Spinal Cord; Vasotocin | 2003 |
Antinociceptive role of oxytocin in the nucleus raphe magnus of rats, an involvement of mu-opioid receptor.
Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Hot Temperature; Male; Naltrexone; Oxytocin; Physical Stimulation; Raphe Nuclei; Rats; Rats, Wistar; Reaction Time; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2003 |
Mu opioid modulation of oxytocin secretion in late pregnant and parturient rats. Involvement of noradrenergic neurotransmission.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Cinnamates; Enzyme-Linked Immunosorbent Assay; Estrogens; Female; Methoxyhydroxyphenylglycol; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Narcotics; Norepinephrine; Oxytocin; Paraventricular Hypothalamic Nucleus; Pregnancy; Progesterone; Rats; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu; Supraoptic Nucleus | 2004 |
Involvement of opioid receptors in the oxytocin-induced antinociception in the central nervous system of rats.
Topics: Animals; Central Nervous System; Male; Naloxone; Naltrexone; Narcotic Antagonists; Oxytocin; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2004 |
Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice.
Topics: Analgesics; Animals; Behavior; Calcium Channel Blockers; Dose-Response Relationship, Drug; Formaldehyde; Mice; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Nimodipine; Oxytocin; Pain; Random Allocation; Receptors, Opioid, delta; Receptors, Opioid, kappa | 2006 |
Involvement of opioid receptors in oxytocin-induced antinociception in the nucleus accumbens of rats.
Topics: Analgesics; Animals; Hot Temperature; Male; Microinjections; Naloxone; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Oxytocin; Pain Measurement; Physical Stimulation; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2007 |
Dehydration-induced modulation of kappa-opioid inhibition of vasopressin neurone activity.
Topics: Action Potentials; Animals; Cholecystokinin; Dehydration; Electrophysiology; Enkephalins; Female; Hypernatremia; Hyponatremia; Immunohistochemistry; In Situ Hybridization; Naltrexone; Narcotic Antagonists; Neurons; Oxytocin; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; RNA, Messenger; Vasopressins | 2009 |
Experiencing neonatal maternal separation increased pain sensitivity in adult male mice: Involvement of oxytocinergic system.
Topics: Analgesics, Opioid; Animals; Female; Hormone Antagonists; Male; Maternal Deprivation; Mice; Naltrexone; Oxytocin; Pain; Pain Threshold; Stress, Psychological; Vasotocin | 2017 |
Oxytocin and Naltrexone Successfully Treat Hypothalamic Obesity in a Boy Post-Craniopharyngioma Resection.
Topics: Administration, Intranasal; Administration, Oral; Child; Craniopharyngioma; Humans; Hypothalamic Diseases; Male; Naltrexone; Neurosurgical Procedures; Obesity; Oxytocin; Pituitary Neoplasms; Treatment Outcome | 2018 |
Effect of combination of peripheral oxytocin and naltrexone at subthreshold doses on food intake, body weight and feeding-related brain gene expression in male rats.
Topics: Animals; Body Weight; Brain; Eating; Gene Expression; Humans; Male; Naltrexone; Oxytocin; Rats | 2021 |